Loading...
OTCMHYEX
Market cap870mUSD
Dec 19, Last price  
2.52USD
1D
-6.92%
1Q
-25.81%
Jan 2017
-99.89%
IPO
-99.99%
Name

Healthy Extracts Inc

Chart & Performance

D1W1MN
OTCM:HYEX chart
P/E
—
P/S
350.26
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
163.62%
Rev. gr., 5y
105.93%
Revenues
2m
+10.41%
115,551162,750128,10567,131748,3771,276,5591,465,7822,251,4692,485,866
Net income
-2m
L+149.80%
-730,872-3,370,935-3,562,075-3,329,517632,776-2,649,257-2,039,575-989,962-2,472,931
CFO
-416k
L+24.12%
-497,847-537,058-672,227-328,751-3,488,099-3,482,641-901,298-334,964-415,749

Profile

Healthy Extracts Inc., through its subsidiaries, researches, develops, and markets natural plant-based products in the United States and internationally. It offers heart health nutritional supplements; and neuro products under the KETONOMICS name that enhance brain health, including memory, cognition, focus, and neuro-energy. The company also provides bergamot products in capsule form under the BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART products labels. It distributes bergamot products through its website and distribution sites. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is based in Littleton, Colorado.
URL
https://healthyextractsinc.com/
IPO date
Oct 13, 2015
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,486
10.41%
2,251
53.60%
1,466
14.82%
Cost of revenue
4,730
4,142
3,916
Unusual Expense (Income)
NOPBT
(2,244)
(1,891)
(2,450)
NOPBT Margin
Operating Taxes
7
52
Tax Rate
NOPAT
(2,244)
(1,898)
(2,503)
Net income
(2,473)
149.80%
(990)
-51.46%
(2,040)
-23.01%
Dividends
Dividend yield
Proceeds from repurchase of equity
(90)
(11)
995
BB yield
0.43%
0.08%
-6.65%
Debt
Debt current
1,128
594
343
Long-term debt
74
Deferred revenue
Other long-term liabilities
1
Net debt
1,183
528
121
Cash flow
Cash from operating activities
(416)
(335)
(901)
CAPEX
(1)
(8)
(96)
Cash from investing activities
(8)
(96)
Cash from financing activities
370
240
1,160
FCF
(1,953)
449
(1,686)
Balance
Cash
19
66
222
Long term investments
Excess cash
149
Stockholders' equity
(18,045)
(15,582)
(14,605)
Invested Capital
20,127
18,053
17,419
ROIC
ROCE
EV
Common stock shares outstanding
2,915
2,854
2,660
Price
7.20
50.00%
4.80
-14.71%
5.63
-21.83%
Market cap
20,991
53.21%
13,701
-8.49%
14,971
5.15%
EV
22,173
14,228
15,091
EBITDA
(2,242)
(1,890)
(2,445)
EV/EBITDA
Interest
65
52
Interest/NOPBT